Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

Fluorouracil 5Oxaliplatin 4Surgical Procedures, Operative 3Radiotherapy 3Neoadjuvant Therapy 3Leucovorin 3Drug Therapy 3Chemoradiotherapy 3Capecitabine 3Irinotecan 2Immune Checkpoint Inhibitors 2Folfox protocol 2Bevacizumab 2sulindac sulfone 1sintilimab 1XELOX 1Water 1Surveys and Questionnaires 1Preoperative Exercise 1Photochemotherapy 1N-dihydrogalactochitosan 1Microwaves 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Leucine-tRNA Ligase 1Injections 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Rectal Neoplasms × HMPL-013 × Clear all
NCT06443671 2024-06-05

PKUCH-R09

Peking University Cancer Hospital & Institute

Phase 2/3 Not yet recruiting
132 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡